Latest Content

Libtayo improved survival and safety outcomes vs chemotherapy in advanced NSCLC, with 23% of patients alive at six years in the EMPOWER-Lung 1 trial.

Dr. Reshma Jagsi discusses optimizing breast cancer care by safely de-escalating surgery and radiation using patient-centered communication

Once the reality set in that my sister was cancer-free and in remission, I realized I was unprepared for what life would look like after cancer.

Physician Dr. Sheri Prentiss advocates for baseline measurements and proactive surveillance to detect and treat breast cancer-related lymphedema early.

New data highlight colorectal cancer rates in younger adults, emphasizing the need for earlier screening, symptom awareness and timely diagnosis.

Nuvalent submitted an NDA for neladalkib to the FDA for patients with previously treated ALK-positive non-small cell lung cancer, based on ALKOVE-1 trial data showing activity.

Histotripsy uses focused ultrasound to treat liver tumors without surgery, needles or radiation, offering a new non-invasive option for patients.

Dr. Sara Nunnery and Dr. Neil Iyengar discuss metabolic health, GLP-1s and prescribing exercise to improve outcomes for breast cancer survivors.

Dry mouth and neck tightness from oral tongue cancer treatment shape daily life, managed with hydration, stretches, therapies and a head and neck Flexitouch device.

Expanding local access to clinical trials improves options by reducing barriers and bringing research opportunities closer to patients with cancer, Dr. Natalie Berger said.

Following her breast cancer diagnosis, Guerdy Abraira utilized genomic testing to gain clarity on her treatment path.

Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health during treatment.

Research shows lifestyle and gut bacteria may drive early-onset colorectal cancer, emphasizing diet and healthy habits to help lower risk.